SCHEMBL21323310

SCHEMBL21323310

COc1ccc(/C=C/C(=O)N2CCC3CN(C(=O)c4ccc5[nH]nnc5c4)C[C@H]3CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 12/20 0.54
▸ KCNH2 Q12809 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ MAPT P10636 2/20 0.48
▸ GAA P10253 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ PTGS2 P35354 2/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ CHRNB2 P17787 1/20 0.44
▸ CHRNB4 P30926 1/20 0.44
▸ CHRNA3 P32297 1/20 0.44
▸ CHRNA7 P36544 1/20 0.44
▸ CHRNA4 P43681 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963768 1.00 GPR183 (0.54) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL21323311 1.00 GPR183 (0.54) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL16963765 1.00 GPR183 (0.54) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL21323086 0.90 GPR183 (0.48) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL16962980 0.90 GPR183 (0.48) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL16962977 0.90 GPR183 (0.48) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL21323342 0.89 ENPP2 (0.46) GPR183KCNH2
SCHEMBL16961758 0.89 ENPP2 (0.46) GPR183KCNH2
SCHEMBL21322990 0.89 GPR183 (0.41) GPR183KCNH2ALDH1A1NPC1RAB9A
SCHEMBL16961762 0.89 ENPP2 (0.46) GPR183KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback